维普中文期刊产品整合服务
7篇 您的检索式:作者名="Drorit"
    题名 作者 年代 出处 被引量
1Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss显示文摘High erythropoietin(Epo)levels are detrimental to bone health in adult organisms.Adult mice receiving high doses of Epo lose bone mass due to suppressed bone formation and increased bone resorption.In humans,high serum Epo levels are linked to fractures in elderly men.Our earlier studies indicated that Epo modulates osteoblast activity;however,direct evidence that Epo acts via its receptor(EpoR)on osteoblasts in vivo is still missing.Here,we created mice lacking EpoR in osteoprogenitor cells to specifically address this gap.Deletion of EpoR in osteoprogenitors(EpoR:Osx-cre,cKO)starting at 5 weeks of age did not alter red blood cell parameters but increased vertebral bone volume by 25%in 12-week-old female mice.This was associated with low bone turnover.Histological(osteoblast number,bone formation rate)and serum(P1NP,osteocalcin)bone formation parameters were all reduced,as were the number of osteoclasts and TRAP serum level.Differentiation of osteoblast precursors isolated from cKO versus control mice resulted in lower expression of osteoblast marker genes including Runx2,Alp,and Col1a1 on day 21,whereas the mineralization capacity was similar.Moreover,the RANKL70PG ratio,which determines the osteoclast-supporting potential of osteoblasts,was substantially decreased by 50%.Similarly,coculturing cKO osteoblasts with control or cKO osteoclast precursors produced significantly fewer osteoclasts than coculture with control osteoblasts.Finally,exposing female mice to Epo pumps(10 U-d_1)for 4 weeks resulted in trabecular bone loss(-25%)and increased osteoclast numbers(1.7-fold)in control mice only,not in cKO mice.Our data show that EpoR in osteoprogenitors is essential in regulating osteoblast function and osteoblast-mediated osteoclastogenesis via the RANKI70PG axis.Thus,osteogenic Epo/EpoR signaling controls bone mass maintenance and contributes to Epo-induced bone loss.Martina Rauner Marta Murray Sylvia Thiele Deepika Watts Drorit Neumann Yankel Gabet Lorenz C.Hofbauer Ben Wielockx 2021Bone Research2021,9,4:3
2Tonsillectomy vs. partial tonsillectomy for OSAS in children—10 years post-surgery follow-up显示文摘Ephraim Eviatar Alexander Kessler Nathan Shlamkovitch Michael Vaiman Drorit Zilber Haim Gavriel 2008International Journal of Pediatric Otorhinolaryngology2008,,5:2
3Tonsillectomy vs. partial tonsillectomy for OSAS in children—10 years post-surgery follow-up显示文摘Ephraim Eviatar Alexander Kessler Nathan Shlamkovitch Michael Vaiman Drorit Zilber Haim Gavriel 2008International Journal of Pediatric Otorhinolaryngology2008,,5:1
4Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement 显示文摘Deborah E Altoon D Drorit A 2007Blood2007,110,7:1
5Evaluation of the potential anti-cancer activity of the antidepressantsertraline in human colon cancer cell lines and in colorectal cancer-xenograftedmice显示文摘Irit Gil-Ad Amichai Zolokov Liat Lomnitski Michal Taler Meital Bar Drorit Luria Edward Ram Abraham Weizman 2008International Journal of Oncology2008,,2:1
6Structure, function, and activation of the erythropoietin receptor显示文摘Hagop Y Gregory L Drorit Neumann 1993Blood1993,81,9:1
7Erythropoietin: The swinging pendulum显示文摘Howard S. Oster Drorit Neumann Michael Hoffman Moshe Mittelman 2012Leukemia Research2012,,8:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费